ZGN trades 0.0% below Wall Street's consensus target of $13.17.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ZGN achieves its forward estimates and maintains a stable P/E multiple of 32.0x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 6, 2026, Ermenegildo Zegna N.V. (ZGN) has a Wall Street consensus price target of $13.17, based on estimates from 6 covering analysts. With the stock currently trading at $13.17, this represents a potential upside of +0.0%. The company has a market capitalization of $3.53B.
Analyst price targets range from a low of $11.00 to a high of $14.50, representing a 27% spread in expectations. The median target of $14.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ZGN trades at a trailing P/E of 31.2x and forward P/E of 32.0x. Analysts expect EPS to grow -37.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $31.75, with bear and bull scenarios of $20.01 and $41.84 respectively. Model confidence stands at 37/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
CPRICapri Holdings Limited | $2.2B | $18.96 | $23.29 | +22.8% | Hold | 13.5x | 54 |
TPRTapestry, Inc. | $29.1B | $144.21 | $173.67 | +20.4% | Buy | 20.7x | 41 |
RLRalph Lauren Corporation | $24.3B | $398.22 | $440.25 | +10.6% | Buy | 24.4x | 48 |
PVHPVH Corp. | $3.5B | $75.23 | $92.00 | +22.3% | Buy | 6.9x | 38 |
HBIHanesbrands Inc. | $2.3B | $6.47 | $7.25 | +12.1% | Buy | 9.8x | 34 |
GIIIG-III Apparel Group, Ltd. | $1.4B | $33.50 | $39.33 | +17.4% | Buy | 11.5x | 29 |
OXMOxford Industries, Inc. | $521M | $34.88 | $41.33 | +18.5% | Buy | 15.6x | 21 |
VFCV.F. Corporation | $6.4B | $16.30 | $20.50 | +25.8% | Hold | 19.8x | 58 |
MOVMovado Group, Inc. | $858M | $37.61 | $50.00 | +32.9% | Hold | 33.2x | 13 |
NKENIKE, Inc. | $65.2B | $44.09 | $53.58 | +21.5% | Buy | 29.4x | 71 |
Quick answers to the most common questions about buying ZGN stock.
The consensus price target for ZGN is $13.17, close to the current price of $13.17 (0.0% implied move). Based on 6 analyst estimates, the stock appears fairly valued near current levels.
ZGN has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $13.17 implies 0.0% upside from current levels.
ZGN trades at a forward P/E of 32.0282x, representing a moderate valuation. With analysts targeting $13.17 (0.0% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $14.5 for ZGN, while the most conservative target is $11. The consensus of $13.17 represents the median expectation. Our quantitative valuation model projects a bull case target of $42 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ZGN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ZGN stock forecast based on 6 Wall Street analysts shows a consensus price target of $13.17, with estimates ranging from $11 (bear case) to $14.5 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $32, with bear/bull scenarios of $20/$42.
Our quantitative valuation model calculates ZGN's fair value at $32 (base case), with a bear case of $20 and bull case of $42. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 37/100.
ZGN trades at a forward P/E ratio of 32.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.2x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
ZGN appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $13.17 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ZGN analyst price targets range from $11 to $14.5, a 27% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $13.17 consensus represents the middle ground. Our model's $20-$42 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.